“Zanidatamab in HER2-Positive Biliary Tract Cancer: A First Narrative Literature Review”. 2025. Journal of Medical Health Research and Psychiatry 2 (2): 1-4. https://doi.org/10.70844/jmhrp.2025.2.2.44.